Superworth

NRC Health PE ratio NRC

Share price divided by earnings per share over the last twelve months, since 2013.

Today, Nov 2, 2026
97.0×
10-year median
35.2×
Against its 10-year history
100th
percentile: 0 is its lowest day, 100 its highest
10-year range
10.0× to 97.0×
Peer median
84.0×

NRC Health's PE ratio is 97.0× as of Nov 2, 2026: a share price of $24.26 against $0.25 of earnings per share over the last twelve months.

That is above its ten-year median of 35.2×, higher than on 100% of days in the last ten years.

Over that time it ranged from 10.0× in Apr 2025 to 97.0× in Nov 2026.

The median for 4 diagnostics and research stocks of a similar size is 84.0×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far97.0×17.3×97.0×
202526.7×10.0×26.7×
202415.4×14.8×34.6×
202334.1×29.1×39.8×
202227.0×22.5×29.8×
202129.4×29.2×39.1×
202029.1×29.1×56.2×
201954.2×37.2×55.4×
201837.9×37.6×59.6×
201758.3×28.2×58.3×
201630.6×21.9×32.1×
201534.1×24.9×35.6×
201426.9×10.6×33.2×
201313.6×6.1×13.7×

Against its peers

Companies in Medical - Diagnostics & Research nearest NRC Health's size, closest first, today.

CompanyPE ratio
NRCNRC Health97.0×
ICCCImmucell132×
VCYTVeracyte35.0×
CDNACareDx35.9×
BLLNBillionToOne170×
Peer median84.0×

Where NRC Health ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on NRC Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.